🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out if oral decitabine-cedazuridine (I...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-01
Trial ID
NCT06351306
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of FT-2102 wh...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-08-27
Trial ID
NCT04013880
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
This phase II trial studies the effect of ASTX727 and dasatinib in treating...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-10-21
Trial ID
NCT05007873
Treatments Being Tested
The main aim of the study is to see if signs and symptoms of myelodysplasti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04985656
Treatments Being Tested
This study is designed to examine blood levels of ASTX727, a fixed-dose com...
Status
Completed
Location
Roswell Park
Start Date
2018-11-08
Trial ID
NCT03813186
Treatments Being Tested
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580
To learn if ASTX727 given alone or in combination with donor lymphocyte inf...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2024-07-01
Trial ID
NCT06297629
Treatments Being Tested